U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 585

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
ChrMT:15485
GRCh38:
ChrMT:15485
MT-CYBProgressive external ophthalmoplegia, Kearns-Sayre syndrome, Leber optic atrophy,
Leigh syndrome, MERRF syndrome, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke,
NARP syndrome
not providedno assertion provided
2.
GRCh37:
ChrMT:12923
GRCh38:
ChrMT:12923
MT-ND5Juvenile myopathy, encephalopathy, lactic acidosis AND stroke, Leber optic atrophy, Leigh syndrome
Likely pathogenic
(Oct 31, 2022)
criteria provided, single submitter
3.
GRCh37:
ChrMT:13289
GRCh38:
ChrMT:13289
MT-ND5Juvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Mar 21, 2022)
criteria provided, single submitter
4.
GRCh37:
ChrMT:14021
GRCh38:
ChrMT:14021
MT-ND5Juvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jan 18, 2022)
criteria provided, single submitter
5.
GRCh37:
ChrMT:13912
GRCh38:
ChrMT:13912
MT-ND5Juvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Dec 14, 2021)
criteria provided, single submitter
6.
GRCh37:
ChrMT:9247
GRCh38:
ChrMT:9247
MT-CO3Juvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Dec 1, 2021)
criteria provided, single submitter
7.
GRCh37:
ChrMT:1616
GRCh38:
ChrMT:1616
MT-TVJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Nov 19, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr15:89872302
GRCh38:
Chr15:89329071
POLG, POLGARFM299VProgressive sclerosing poliodystrophy, not provided, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke
Uncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
ChrMT:14465
GRCh38:
ChrMT:14465
MT-ND6Juvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely pathogenic
(Oct 17, 2019)
criteria provided, single submitter
10.
GRCh37:
ChrMT:13763
GRCh38:
ChrMT:13763
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
11.
GRCh37:
ChrMT:13094
GRCh38:
ChrMT:13094
MT-ND5Mitochondrial diseasePathogenic
(Jul 25, 2022)
reviewed by expert panel
FDA Recognized Database
12.
GRCh37:
ChrMT:13046
GRCh38:
ChrMT:13046
MT-ND5Juvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely pathogenic
(Oct 17, 2019)
criteria provided, single submitter
13.
GRCh37:
ChrMT:12418
GRCh38:
ChrMT:12418
MT-ND5Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, Leber optic atrophy, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke
Pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
ChrMT:4142
GRCh38:
ChrMT:4142
MT-ND1Juvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely pathogenic
(Oct 17, 2019)
criteria provided, single submitter
15.
GRCh37:
ChrMT:3502
GRCh38:
ChrMT:3502
MT-ND1Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, Juvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely pathogenic
(Apr 11, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
ChrMT:3380
GRCh38:
ChrMT:3380
MT-ND1Juvenile myopathy, encephalopathy, lactic acidosis AND strokePathogenic
(Oct 17, 2019)
criteria provided, single submitter
17.
GRCh37:
ChrMT:16021
GRCh38:
ChrMT:16021
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
18.
GRCh37:
ChrMT:16015-16016
GRCh38:
ChrMT:16015-16016
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
19.
GRCh37:
ChrMT:16017
GRCh38:
ChrMT:16017
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
20.
GRCh37:
ChrMT:16013
GRCh38:
ChrMT:16013
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
21.
GRCh37:
ChrMT:16011
GRCh38:
ChrMT:16011
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
22.
GRCh37:
ChrMT:16003
GRCh38:
ChrMT:16003
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
23.
GRCh37:
ChrMT:16002
GRCh38:
ChrMT:16002
MT-TPMERRF syndrome, Juvenile myopathy, encephalopathy, lactic acidosis AND strokePathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
ChrMT:15995
GRCh38:
ChrMT:15995
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
25.
GRCh37:
ChrMT:15994
GRCh38:
ChrMT:15994
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
26.
GRCh37:
ChrMT:15992
GRCh38:
ChrMT:15992
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
27.
GRCh37:
ChrMT:15984
GRCh38:
ChrMT:15984
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
28.
GRCh37:
ChrMT:15983
GRCh38:
ChrMT:15983
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
29.
GRCh37:
ChrMT:15978
GRCh38:
ChrMT:15978
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
30.
GRCh37:
ChrMT:15977
GRCh38:
ChrMT:15977
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
31.
GRCh37:
ChrMT:15976
GRCh38:
ChrMT:15976
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
32.
GRCh37:
ChrMT:15970
GRCh38:
ChrMT:15970
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
33.
GRCh37:
ChrMT:15968
GRCh38:
ChrMT:15968
MT-TPJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
34.
GRCh37:
ChrMT:15952
GRCh38:
ChrMT:15952
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
35.
GRCh37:
ChrMT:15951
GRCh38:
ChrMT:15951
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
36.
GRCh37:
ChrMT:15949
GRCh38:
ChrMT:15949
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
37.
GRCh37:
ChrMT:15947
GRCh38:
ChrMT:15947
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
38.
GRCh37:
ChrMT:15946
GRCh38:
ChrMT:15946
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
39.
GRCh37:
ChrMT:15944
GRCh38:
ChrMT:15944
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
40.
GRCh37:
ChrMT:15939-15940
GRCh38:
ChrMT:15939-15940
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
41.
GRCh37:
ChrMT:15942
GRCh38:
ChrMT:15942
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
42.
GRCh37:
ChrMT:15941
GRCh38:
ChrMT:15941
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
43.
GRCh37:
ChrMT:15940
GRCh38:
ChrMT:15940
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
44.
GRCh37:
ChrMT:15940
GRCh38:
ChrMT:15940
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
45.
GRCh37:
ChrMT:15939
GRCh38:
ChrMT:15939
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
46.
GRCh37:
ChrMT:15938
GRCh38:
ChrMT:15938
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
47.
GRCh37:
ChrMT:15937
GRCh38:
ChrMT:15937
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
48.
GRCh37:
ChrMT:15937
GRCh38:
ChrMT:15937
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
49.
GRCh37:
ChrMT:15934
GRCh38:
ChrMT:15934
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
50.
GRCh37:
ChrMT:15936
GRCh38:
ChrMT:15936
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
51.
GRCh37:
ChrMT:15936
GRCh38:
ChrMT:15936
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
52.
GRCh37:
ChrMT:15935
GRCh38:
ChrMT:15935
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
53.
GRCh37:
ChrMT:15932
GRCh38:
ChrMT:15932
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
54.
GRCh37:
ChrMT:15930
GRCh38:
ChrMT:15930
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
55.
GRCh37:
ChrMT:15929
GRCh38:
ChrMT:15929
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
56.
GRCh37:
ChrMT:15926
GRCh38:
ChrMT:15926
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
57.
GRCh37:
ChrMT:15925
GRCh38:
ChrMT:15925
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
58.
GRCh37:
ChrMT:15924
GRCh38:
ChrMT:15924
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
59.
GRCh37:
ChrMT:15921
GRCh38:
ChrMT:15921
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
60.
GRCh37:
ChrMT:15916
GRCh38:
ChrMT:15916
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
61.
GRCh37:
ChrMT:15915
GRCh38:
ChrMT:15915
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokePathogenic
(Jul 12, 2019)
criteria provided, single submitter
62.
GRCh37:
ChrMT:15914
GRCh38:
ChrMT:15914
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
63.
GRCh37:
ChrMT:15913
GRCh38:
ChrMT:15913
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
64.
GRCh37:
ChrMT:15911
GRCh38:
ChrMT:15911
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
65.
GRCh37:
ChrMT:15909
GRCh38:
ChrMT:15909
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
66.
GRCh37:
ChrMT:15909
GRCh38:
ChrMT:15909
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
67.
GRCh37:
ChrMT:15908
GRCh38:
ChrMT:15908
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
68.
GRCh37:
ChrMT:15907
GRCh38:
ChrMT:15907
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
69.
GRCh37:
ChrMT:15905
GRCh38:
ChrMT:15905
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
70.
GRCh37:
ChrMT:15904
GRCh38:
ChrMT:15904
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
71.
GRCh37:
ChrMT:15903
GRCh38:
ChrMT:15903
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
72.
GRCh37:
ChrMT:15902
GRCh38:
ChrMT:15902
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
73.
GRCh37:
ChrMT:15900
GRCh38:
ChrMT:15900
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
74.
GRCh37:
ChrMT:15897
GRCh38:
ChrMT:15897
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
75.
GRCh37:
ChrMT:15895
GRCh38:
ChrMT:15895
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
76.
GRCh37:
ChrMT:15894
GRCh38:
ChrMT:15894
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
77.
GRCh37:
ChrMT:15893
GRCh38:
ChrMT:15893
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
78.
GRCh37:
ChrMT:15892
GRCh38:
ChrMT:15892
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
79.
GRCh37:
ChrMT:15891
GRCh38:
ChrMT:15891
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
80.
GRCh37:
ChrMT:15890
GRCh38:
ChrMT:15890
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
81.
GRCh37:
ChrMT:15889
GRCh38:
ChrMT:15889
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
82.
GRCh37:
ChrMT:15888
GRCh38:
ChrMT:15888
MT-TTJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
83.
GRCh37:
ChrMT:14739
GRCh38:
ChrMT:14739
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokePathogenic
(Jul 12, 2019)
criteria provided, single submitter
84.
GRCh37:
ChrMT:14729
GRCh38:
ChrMT:14729
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
85.
GRCh37:
ChrMT:14727
GRCh38:
ChrMT:14727
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
86.
GRCh37:
ChrMT:14716
GRCh38:
ChrMT:14716
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
87.
GRCh37:
ChrMT:14710
GRCh38:
ChrMT:14710
MT-TEMitochondrial diseaseUncertain significance
(Dec 15, 2022)
reviewed by expert panel
FDA Recognized Database
88.
GRCh37:
ChrMT:14696
GRCh38:
ChrMT:14696
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
89.
GRCh37:
ChrMT:14696
GRCh38:
ChrMT:14696
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
90.
GRCh37:
ChrMT:14693
GRCh38:
ChrMT:14693
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
91.
GRCh37:
ChrMT:14691
GRCh38:
ChrMT:14691
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely benign
(Jul 12, 2019)
criteria provided, single submitter
92.
GRCh37:
ChrMT:14690
GRCh38:
ChrMT:14690
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
93.
GRCh37:
ChrMT:14687
GRCh38:
ChrMT:14687
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
94.
GRCh37:
ChrMT:14684
GRCh38:
ChrMT:14684
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
95.
GRCh37:
ChrMT:14683
GRCh38:
ChrMT:14683
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
96.
GRCh37:
ChrMT:14681
GRCh38:
ChrMT:14681
MT-TEJuvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
97.
GRCh37:
ChrMT:12335
GRCh38:
ChrMT:12335
MT-TL2Juvenile myopathy, encephalopathy, lactic acidosis AND strokeLikely pathogenic
(Jul 12, 2019)
criteria provided, single submitter
98.
GRCh37:
ChrMT:12318
GRCh38:
ChrMT:12318
MT-TL2Juvenile myopathy, encephalopathy, lactic acidosis AND strokeUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
99.
GRCh37:
ChrMT:12311
GRCh38:
ChrMT:12311
MT-TL2Juvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
100.
GRCh37:
ChrMT:12305-12306
GRCh38:
ChrMT:12305-12306
MT-TL2Juvenile myopathy, encephalopathy, lactic acidosis AND strokeBenign
(Jul 12, 2019)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination